BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced the Phase 3 clinical d…
CORRECTING and REPLACING MEDIA ALERT: CSIRO to Host Silicon Valley Innovation Summit & Showcase
PALO ALTO, Calif.–(BUSINESS WIRE)–Please replace the release dated February 11, 2016 with the following corrected version due to multiple revisions. The corrected release reads: MEDIA ALERT: CSIRO TO HOST SILICON VALLEY INNOVATION SUMMIT & SHOWCASE Australia’s Scientific and Research Organization Will Highlight New Breakthroughs and Outline Roadmap for Collaboration with Silicon Valley Technology Community CSIRO, the scientific and research organization for Australia responsible for the b
Global Prescription/Rx Sunglass Market Worth USD 3.76 Billion by 2022 – Analysis, Technologies & Forecast Report 2016-2022 – Key Vendors: Bausch & Lomb, Carl Zeiss, Charmant Group – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/g5lftv/prescriptionrx) has announced the addition of the “Prescription/Rx Sunglass Market Analysis By Lens Material (Glass, CR-39, Polycarbonate, Polyurethane) An…
Signs of AMD Regress With Statin Treatment
High-risk signs of dry age-related macular degeneration (AMD) regress with intensive statin treatment, according to results from a pilot interventional study. Reuters Health Information
Uncategorized
Iridex receives CE mark for Cyclo G6 laser system in Europe
Iridex has received CE mark to commercialize the Cyclo G6 laser system in Europe for the treatment of glaucoma and its symptoms, the company announced in a press release. The Cyclo G6 laser system is designed to treat a range of glaucoma diseases and features Iridex’s MicroPulse tissue-sparing technology, as well as a family of single-use probes that connect to a laser console.
Uncategorized
Senate committee proposes updates to FDA application requirements for reusable devices
In a recent session, the Senate Committee on Health, Education, Labor and Pensions favorably reported a bill requiring manufacturers of reusable medical devices to submit cleaning instructions and validation data to the FDA before bringing these devices to market. The bill also would require the FDA to develop guidance on when manufacturers should seek clearance from the agency before marketing their products.The “Preventing Superbugs and Protecting Patients Act” (S. 2503), sponsored Sen. Patty Murray, D-Wash., references several incidents of drug-resistant infections related to closed-channel duodenoscopes brought to light in the past year. According to a recent investigation, also launched by Murray, there were 25 such incidents affecting 250 patients worldwide from 2013 to 2015. Along with identifying faults among device manufacturers and hospitals, the investigation found that the FDA’s surveillance system for ensuring medical device safety did not alert hospitals that scope designs hindered effective cleaning for nearly a year and a half.